5 | EMPO Financials 07/16/2014 13:58:47 Empowered | Emylers | 07/16/2014 2:58:43 PM |
4 | Latest Empowered Products (EMPO) Headlines | Stock_Tracker | 03/09/2014 5:59:01 PM |
3 | EMPO 0.3401 Stock Charts $EMPO 1 Month Chart | chartguy89 | 03/07/2014 1:48:09 AM |
2 | EMPO Stock Charts Last: -0.1548 Tuesday, February | chartguy89 | 02/25/2014 10:38:09 PM |
1 | EMPO Promos 12/10/07 (15) see more at: | PS24 | 10/07/2012 8:01:16 PM |
Recent Articles
- Meizu Impresses with AI Innovations at Global Mobility Expo
- EHR Apps Market Driven by Innovations, Expected to Reach $1.66B
- Exploring Next-Generation Sequencing Data Analysis Growth
- Transforming Retail Financing with LendPro and SPLICE Partnership
- Final Countdown: Join the Exciting $XPL Presale Now!
- Exploring Spark Retainers & BiteSync Class II Corrector Launch
- XenDex Sees Surge in Community Growth and Presale Demand
- Understanding Key Economic Strategies from China's Leadership Meeting
- Financière de Tubize Announces Annual Dividend Distribution
- Celebrating Cinema at the 20th China Film Huabiao Awards
- Movado Group Faces SEC Scrutiny, Rosen Law Firm Steps In
- Experience the Thrill of Japan Open Poker Tour 2025
- A.I.S. Resources Completes Successful Private Placement Initiative
- Ready Capital Shareholder Legal Updates: Know Your Rights
- Investors Urged to Act: Lawsuits Filed Against e.l.f. Beauty
- Understanding Your Rights as a Bancorp Investor in Legal Matters
- Important Update for Viatris Investors: Legal Action Insights
- AppLovin Investors Reminded of Important Class Action Deadline
- Investors Have a Deadline to Join NET Power Class Action
- Fluence Energy Class Action Update: Important Deadline Approaches
- AppLovin Corporation Faces Shareholder Class Action Opportunities
- Formosa Pharmaceuticals Partners With Saval For New Eye Treatment
- Antengene Showcases Innovative Therapeutics at AACR Event
- 51Talk Online Education Group Releases Key Annual Report for 2024
- Skye Bioscience Unveils Stock Option Grant for New Employee
- Innovent Celebrates NMPA Approval of Limertinib for Lung Cancer Treatment
- Willow Biosciences Reveals Results from Recent Shareholder Meeting
- Investigation into Bitfarms Ltd: What Investors Should Know
- Investigation into HealthEquity, Inc. Sparks Investor Interest
- Creative Science Expands Horizons with Astaria Global Acquisition
- Investors Encouraged to Join Canopy Growth Class Action Suit
- Rosen Law Firm Initiates Investigation for Bitfarms Investors
- Agnico Eagle's 2025 Shareholder Meeting: Directors Elected
- Orbia's Exciting Offer: Tender for Senior Notes Unveiled
- Concord Medical Submits Annual Report for Fiscal Year 2024
- BankFirst Capital Corporation Posts Strong Q1 Performance
- Espire Dental Unifies Workforce at Engaging Conference Event
- Aliya Health Group Welcomes New Leaders to Enhance Care
- 17 Education & Technology Group Inc. Releases Annual Financial Report
- Kellanova Board Approves New $0.57 Dividend for Shareholders
- Exploring Christian Zionism: New Podcast Series Launches
- Graze Robotics and Invited Launch Pioneering Mowing Initiative
- Medtronic's OmniaSecure Lead Revolutionizes Cardiac Care Innovations
- Celebrate Planning with Plum Paper's Customer Appreciation Sale
- Innovative Grant Initiative to Foster Community Health Equity
- Investigating the HarborOne Bancorp and Eastern Bankshares Deal
- Celularity Faces Delisting Notice From Nasdaq Over Fees
- Paul Mueller Company Q1 Earnings Show Significant Growth
- Trillion Energy Takes Major Steps to Restructure Debt Efficiently
- Credicorp Ltd. Files Annual Report Showcasing Growth Insights